Be part of the knowledge.™

Physiogenomics and Diabetes

Media Formats

ReachMD Healthcare Image

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
Is the risk of the glitazones worth the benefit? What if you could predict which patients were susceptible? Dr. Ruaño discusses with host Dr. Leslie Lundt how diabetes patients may benefit from the rapidly growing field of physiogenomics.

Gualberto Ruano, MD, PhD

Gualberto Ruano, MD, PhD

Leslie P. Lundt, MD

Leslie P. Lundt, MD

Recommended

Details

Presenters

Overview
Is the risk of the glitazones worth the benefit? What if you could predict which patients were susceptible? Dr. Ruaño discusses with host Dr. Leslie Lundt how diabetes patients may benefit from the rapidly growing field of physiogenomics.

Gualberto Ruano, MD, PhD

Gualberto Ruano, MD, PhD

Leslie P. Lundt, MD

Leslie P. Lundt, MD

Program Chapters

Segment Chapters

Playlist:

Recommended

Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy

Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective

IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis

Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies

Diagnosis and Management of Metastatic PDAC

TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management

A Practical Guide to Prescribing in HF

Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA